CARE Ratings Limited (NSE: CARERATING | BSE: 535789)
Source: CARE Ratings Limited Annual Report FY 2025-26 / Fiscal Year Ended March 31, 2026
📋 Quick Facts: Company Snapshot
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | CARE Ratings Limited |
| Corporate Identity Number (CIN) | L67190MH1993PLC071691 |
| Date of Incorporation / Founding Year | 1993 |
| Registered Office & Corporate Headquarters | 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai – 400022, Maharashtra, India |
| Telephone & Investor Relations Contact | Tel: +91-22-67543456 | Fax: +91-22-67543457 | Email: investor.relations@careedge.in |
| Chairman | V. Chandrasekaran (Chairman, Non-Executive Independent Director) |
| Managing Director & Group CEO | Mehul Pandya (Managing Director & Group CEO) |
| Chief Financial Officer (CFO) | Jinesh Shah (Group Chief Financial Officer) |
| Company Secretary (CS) & Compliance Officer | Manoj Kumar C.V. (Company Secretary and Compliance Officer) |
| Promoter & Holding Group | Professionally Managed Company (No identified promoter or promoter group) |
| Industry / Sector Classification | Financial Services / Credit Rating Agency (NIC Code: 66190) |
| Total Employees / Workforce (BRSR Standalone) | 648 Total Employees (608 Permanent Employees, 40 Other than Permanent) |
| Manufacturing Plants / Branches / Offices Count | 10 Offices across India; 0 Plants |
| Countries / States Served | National: 10 branches across 7 Indian states | International: Operating across 4 continents (subsidiary operations in GIFT City, Mauritius, Nepal, and South Africa) |
| Statutory Auditors | M/s. B S R & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W-100022) |
| Registrar and Share Transfer Agent (RTA) | KFin Technologies Limited (Selenium Tower B, Plot 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500032, Telangana) |
🏢 The Corporate Identity: Who They Are & Where They Came From
The Big Picture
CARE Ratings Limited (widely recognized under its group identity, CareEdge Group) stands as India’s second-largest credit rating agency, established in 1993. Licensed by the Securities and Exchange Board of India (SEBI) and accredited by the Reserve Bank of India (RBI) under the Basel III Capital Regulations, the institution forms a structural pillar within India’s debt capital markets and banking system. Operating as a knowledge-led financial intelligence conglomerate, CareEdge enables capital formation by assigning independent, rigorous credit ratings that guide institutional investors, commercial banks, public sector undertakings, and regulatory authorities.
Over three decades of operational history, the organization has expanded beyond credit ratings into an integrated analytics, consulting, sustainability evaluation, and cross-border ratings platform. The group’s operational footprint encompasses the rating of bank loan facilities, corporate debentures, commercial papers, hybrid debt instruments, structured finance obligations, infrastructure investment trusts (InvITs), and real estate investment trusts (REITs). With over 33 years of institutional standing, CareEdge has evaluated more than ₹2.58 Crores crore of aggregate debt and executed over 1,01,111 rating assignments across multiple industries and public sectors.
CareEdge operates through specialized subsidiaries spanning India, GIFT City (IFSC), Mauritius, South Africa, and Nepal, positioning the brand across four continents:
- India’s Second-Largest Credit Rating Agency: Anchors debt evaluations across domestic capital markets and banking systems with 4,667 companies under coverage by the end of FY 2025-26.
- Pioneering Sovereign Ratings Footprint: Through CareEdge Global IFSC Limited, the company has expanded sovereign credit coverage to 45 countries, accounting for over 85% of global Gross Domestic Product (GDP).
- Domestic Market Leadership in ESG Ratings: CARE ESG Ratings Limited commands a 58% market share in India’s Category 1 Issuer-Pays ESG Rating Provider segment.
- Cross-Border Scale: Oversees more than USD 8 billion of rated debt across multinational corporations, sovereigns, and infrastructure projects via its GIFT City international operations.
The Founders, Promoters & Their Legacy
Unlike traditional Indian business conglomerates controlled by family promoters, CARE Ratings Limited is an institutionally held, professionally managed corporate entity. The company has no identified promoter or promoter group, nor does it operate under any controlling shareholder or nominee director. It was founded in 1993 with backing from premier domestic public financial institutions and commercial banks, notably the Life Insurance Corporation of India (LIC) and other institutional lenders, to foster an analytical framework for Indian corporate debt evaluation.
This lineage ensures complete managerial and analytical independence—a regulatory necessity for credit rating agencies registered under SEBI (Credit Rating Agencies) Regulations, 1999. Fiduciary and strategic decisions are governed by a majority-independent Board of Directors, ensuring that rating actions, methodological criteria, and corporate governance stay insulated from commercial conflicts of interest.
The Journey: History & Evolution
The historical evolution of CareEdge Group reflects the deepening sophistication of India’s capital markets and the group’s global footprint:
- 1993: CARE Ratings commenced operations as an accredited credit rating agency in India to support domestic bond and bank borrowing assessments.
- 2012: Marked a defining capital milestone by executing an Initial Public Offering (IPO) subscribed more than 34 times, culminating in listings on BSE Limited and the National Stock Exchange of India Limited.
- 2014: Expanded its international presence by incorporating CARE Ratings (Africa) Private Limited in Mauritius, introducing structured credit rating frameworks to African financial ecosystems.
- 2018: Established CARE Ratings Nepal Limited, expanding cross-border analytical capabilities into the South Asian Association for Regional Cooperation (SAARC) market.
- 2021: Rebranded to “CareEdge Group,” establishing a unified market identity and transitioning from a pure-play rating agency to a financial intelligence and risk solutions group.
- 2022: Integrated CARE Advisory Research & Training with CARE Analytics and Advisory Private Limited, building dedicated practices around financial risk modeling, BFSI analytics, and corporate consultancy.
- 2023: Celebrated 30 years of operations with the launch of its “CareEdge Conversations” engagement platform.
- 2024: Incorporated CareEdge Global IFSC Limited in GIFT City as India’s first CRA licensed to issue sovereign ratings globally; secured regulatory CRA licensing in South Africa via FSCA; and gained Category I ESG Provider registration under SEBI for CARE ESG Ratings Limited.
- 2025-2026: CareEdge Global achieved RBI accreditation as an eligible International Credit Rating Agency, scaled its sovereign coverage to 45 countries, and entered the top four sovereign rating agencies globally by country coverage (excluding domestic Chinese agencies). Concurrently, CareEdge launched “PaRRVA” in partnership with NSE and rolled out “ReInvitEdge” and “EdgeAvira.AI”.
The Corporate Umbrella
The operating architecture of CareEdge Group is divided into two primary wings: Credit Rating Entities and Non-Rating Entities. The parent company, CARE Ratings Limited, directly holds equity in six operating subsidiaries, ensuring regulatory ring-fencing between commercial advisory services and regulated credit opinions.
The rating wing houses CARE Ratings Limited (Domestic CRA), CareEdge Global IFSC Limited (100% owned international CRA in GIFT City), CARE Ratings (Africa) Private Limited (78% owned full-service CRA in Mauritius), CARE Ratings South Africa (Pty) Limited (a wholly owned step-down subsidiary of CRAF licensed by FSCA), and CARE Ratings Nepal Limited (51% owned CRA in Nepal). The non-rating wing comprises CARE Analytics and Advisory Private Limited (100% owned FinTech, risk modeling, and advisory arm) and CARE ESG Ratings Limited (100% owned Category I ESG rating provider).
⚙️ The Business Engine: What They Do & Where They Operate
The Core Divisions
In accordance with Ind AS 108 Operating Segments, the Group’s operations are divided into two reportable business divisions: Ratings and Related Services, and Others (encompassing research, advisory, financial risk management solutions, and ESG evaluation services).
| Reportable Segment (Ind AS 108) | Segment Revenue (FY 2025-26) (₹ in Crores) | % Share of Total Revenue | Segment Results / PBIT (FY 2025-26) (₹ in Crores) | Segment Assets (FY 2025-26) (₹ in Crores) | Segment Liabilities (FY 2025-26) (₹ in Crores) |
|---|---|---|---|---|---|
| Ratings and Related Services | 423.37 | 89.49% | 231.61 | 963.28 | 124.05 |
| Others (Analytics, Advisory, ESG) | 49.70 | 10.51% | (0.14) | 46.62 | 37.56 |
| Unallocable / Inter-Segment Adjustments | – | – | 6.37 | 94.83 | – |
| Total Group Consolidated | 473.07 | 100.00% | 237.84 | 1,104.74 | 161.61 |
Ratings and Related Services generate the foundation of group profitability, operating with high operating leverage and generating ₹231.61 Crores in segment profit. The “Others” vertical represents high-growth diversification across FinTech algorithms, risk consulting, valuation, and sustainability evaluations, closing FY 2025-26 near break-even at the operating segment level as developmental and technological investments scale up.
The Product & Service Catalog
CareEdge provides risk analysis, debt evaluation, and data intelligence services across its corporate and institutional clients:
- Credit Rating Services (Domestic): Bank Loan Ratings (BLR), ratings of Non-Convertible Debentures (NCDs), commercial papers, bonds, hybrid instruments, certificates of deposit, structured debt finance, security receipts, and monitoring agency services for capital market issuances. Ratings for the standalone entity accounted for 96.38% of standalone turnover (NIC Code: 66190).
- Global & Sovereign Ratings: Comprehensive sovereign evaluations for national governments, cross-border corporate ratings, foreign-currency debt assessments, and ‘Use of Proceeds’ certifications delivered through CareEdge Global IFSC Limited.
- CareEdge Analytics Solutions: Advanced proprietary FinTech product suite comprising CredEdge (intelligent credit origination and underwriting), IntelEdge (continuous corporate credit monitoring, covenant tracking, and early warning signal generation), and Kalypto (regulatory capital and risk compliance calculation engine).
- CareEdge Advisory Practices: Comprehensive techno-economic viability (TEV) studies, equity and enterprise valuations, fairness opinions, infrastructure asset monetization frameworks, industry research subscriptions, and municipal finance consulting.
- Sustainability & ESG Assessment: Comprehensive Business Responsibility and Sustainability Reporting (BRSR) compliance advisory, Second Party Opinions (SPO) for green, social, and sustainability-linked debt issuances, Third Party Reviews (TPRs), and SEBI-accredited Category I ESG provider scores.
The Names You Know
CareEdge has created proprietary analytical platforms that serve as operating brands within the financial ecosystem:
- EdgeAvira.AI: A generative AI and machine learning-powered platform designed for commercial banks and NBFCs, driving automated credit underwriting, document processing, and predictive early-warning risk systems. EdgeAvira powers the CredEdge, IntelEdge, and Kalypto product lines.
- ReInvitEdge: An institutional analytics and data platform developed under SEBI guidance, providing asset-level intelligence, valuation models, participant benchmarking, and financial transparency across India’s REIT and InvIT markets.
- PaRRVA (Past Risk and Return Verification Agency): A verification initiative launched jointly with the National Stock Exchange of India (NSE) under SEBI guidelines to independently verify past risk-return track records for registered investment advisors, research analysts, and trading members.
- EdgeSphere & Foresights: CareEdge’s macro research publications, with EdgeSphere serving as the global sovereign risk outlook and Foresights providing monthly macroeconomic and sectoral credit assessments.
Mapping the Domestic & Global Reach
While the Indian subcontinent represents the group’s primary revenue base, cross-border geographic diversification has accelerated through its subsidiaries in GIFT City, Mauritius, South Africa, and Nepal.
| Geographic Market | Consolidated Revenue (FY 2025-26) (₹ in Crores) | Consolidated Revenue (FY 2024-25) (₹ in Crores) | % Share (FY 2025-26) | Latest YoY (%) |
|---|---|---|---|---|
| Within India | 430.52 | 372.66 | 91.01% | +15.53% |
| Outside India (International) | 42.55 | 29.65 | 8.99% | +43.51% |
| Total Consolidated Revenue | 473.07 | 402.32 | 100.00% | +17.59% |
International revenues delivered an expansion of 43.49% during FY 2025-26, outpacing domestic growth and expanding international contribution to 8.99% of total group turnover. This surge was catalyzed by cross-border sovereign and corporate mandates undertaken through CareEdge Global IFSC, expansion in debt rated by CareEdge Africa (rising 30% YoY to USD 4 billion), and consistent growth in Nepal.
The Brick & Mortar Footprint
CareEdge operates via a hub-and-spoke operational network centered at its corporate headquarters in Mumbai, backed by nine regional offices across Indian industrial corridors and three international corporate hubs:
- Headquarters & Registered Office: Godrej Coliseum, Sion (East), Mumbai, Maharashtra.
- Western Regional Network: Mumbai (Wall Street, Andheri East), Ahmedabad (Titanium, Satellite), Pune (Pride Kumar Senate, Bhamburda), and GIFT City (IFSC, Gandhinagar).
- Northern Regional Network: Noida (Berger Tower, Sector 16B, Gautam Budh Nagar, UP).
- Southern Regional Network: Bengaluru (Prestige Meridian, M.G. Road), Chennai (Spencer Plaza, Anna Salai), Hyderabad (Ashoka Scintilla, Himayat Nagar), and Coimbatore (Manchester Square, Puliakulam Road).
- Eastern Regional Network: Kolkata (Apeejay House, 15 Park Street, West Bengal).
- International Operational Bases: Ebene, Mauritius (CareEdge Africa); Sandton, Johannesburg, South Africa (CareEdge South Africa); and Kathmandu, Nepal (CareEdge Nepal).
📊 The Financial Health: The Numbers Simplified
Earnings, Expenses, & Take-Home Profits
The Consolidated Statement of Profit and Loss illustrates operating performance for the fiscal years ended March 31, 2026, and March 31, 2025, prepared under Ind AS Schedule III.
| Consolidated Statement of Profit and Loss (₹ in Crores) | FY 2025-26 | FY 2024-25 | Latest YoY (%) |
|---|---|---|---|
| I. Revenue from Operations | 473.07 | 402.32 | +17.59% |
| II. Other Income | 54.81 | 50.75 | +8.00% |
| III. Total Income (I + II) | 527.89 | 453.07 | +16.51% |
| IV. Employee Benefit Expenses | 214.67 | 188.92 | +13.63% |
| V. Finance Costs | 2.49 | 2.11 | +18.01% |
| VI. Depreciation and Amortisation Expense | 14.37 | 11.72 | +22.61% |
| VII. Other Expenses | 61.00 | 58.05 | +5.08% |
| VIII. Total Expenses (IV to VII) | 292.53 | 260.81 | +12.16% |
| IX. Profit Before Exceptional Items and Tax (III – VIII) | 235.35 | 192.27 | +22.41% |
| XI. Profit Before Tax Expense (IX – X) | 235.35 | 192.27 | +22.41% |
| (i) Current Tax | 62.18 | 51.46 | +20.83% |
| (ii) Adjustment of Tax Relating to Earlier Periods | 0.04 | 0.18 | -77.78% |
| (iii) Deferred Tax | (0.56) | 0.62 | N/M |
| XII. Total Tax Expense | 61.66 | 52.26 | +17.99% |
| XIII. Profit for the Year (XI – XII) | 173.70 | 140.00 | +24.07% |
| Owners of the Parent | 171.18 | 137.24 | +24.73% |
| Non-Controlling Interest | 2.52 | 2.76 | -8.70% |
| A. (i) Items not reclassified to profit or loss | (0.10) | (0.36) | -72.22% |
| (ii) Income tax relating to items not reclassified | 0.02 | (0.45) | N/M |
| B. (i) Items reclassified to profit or loss | 2.67 | 0.54 | +394.44% |
| XV. Other Comprehensive Income / (Expense) for the Year | 2.59 | (0.26) | N/M |
| XVII. Total Comprehensive Income for the Year (XIII + XV) | 176.29 | 139.74 | +26.16% |
| Attributable to Owners of the Parent | 173.73 | 136.98 | +26.83% |
| Attributable to Non-Controlling Interest | 2.56 | 2.76 | -7.25% |
| Basic (₹) | 0.57 | 0.46 | +23.91% |
| Diluted (₹) | 0.57 | 0.46 | +23.91% |
Operating revenue expanded by 17.59% YoY to reach ₹473.07 Crores (₹473.07 crore), demonstrating resilient surveillance fee flows, gains in securitization ratings, and an uptick in international advisory engagements. Concurrently, disciplined expenditure oversight restricted total expense growth to 12.16%, allowing operating leverage to expand Consolidated Profit After Tax by 24.07% to ₹173.70 Crores (₹173.70 crore). Consolidated PAT margin on Total Income strengthened to 32.91% (36.72% on Revenue from Operations), up from 30.90% (34.80% on Revenue from Operations) in FY 2024-25, lifting Basic EPS to ₹57.06 per share.
Assets, Borrowings, & Net Worth
The Consolidated Balance Sheet details the capital architecture, asset distribution, and zero-debt profile of the CareEdge Group.
| Consolidated Balance Sheet (₹ in Crores) | As at March 31, 2026 | As at March 31, 2025 | Latest YoY (%) |
|---|---|---|---|
| a. Property, Plant and Equipment | 81.33 | 79.94 | +1.74% |
| b. Right-of-Use Assets | 23.16 | 21.62 | +7.12% |
| c. Goodwill | 7.95 | 7.95 | 0.00% |
| d. Other Intangible Assets | 9.96 | 9.71 | +2.57% |
| e. Intangible Assets Under Development | 5.32 | 2.92 | +82.19% |
| (i) Investments | 66.34 | 134.07 | -50.52% |
| (ii) Loans | 1.44 | 1.14 | +26.32% |
| (iii) Other Financial Assets | 231.00 | 6.43 | +3492.53% |
| g. Deferred Tax Assets | 0.17 | 0.01 | +1600.00% |
| h. Other Non-Current Assets | 0.76 | 1.82 | -58.24% |
| Total Non-Current Assets | 427.43 | 265.62 | +60.92% |
| (i) Investments | 20.54 | – | – |
| (ii) Trade Receivables | 35.04 | 32.09 | +9.19% |
| (iii) Cash and Cash Equivalents | 42.60 | 48.82 | -12.74% |
| (iv) Bank Balances other than Cash & Cash Equivalents | 86.42 | 48.19 | +79.33% |
| (v) Loans | 1.80 | 1.24 | +45.16% |
| (vi) Other Financial Assets | 471.68 | 550.24 | -14.28% |
| b. Current Tax Assets (Net) | 7.92 | 4.18 | +89.47% |
| c. Other Current Assets | 11.32 | 7.38 | +53.39% |
| Total Current Assets | 677.31 | 692.13 | -2.14% |
| TOTAL ASSETS | 1,104.74 | 957.74 | +15.35% |
| a. Equity Share Capital | 30.05 | 29.93 | +0.40% |
| b. Share Application Money Pending Allotment | 0.13 | – | – |
| c. Other Equity | 902.27 | 776.34 | +16.22% |
| Equity Attributable to Owners of Parent | 932.45 | 806.27 | +15.65% |
| Non-Controlling Interests | 10.68 | 9.23 | +15.71% |
| Total Equity | 943.13 | 815.50 | +15.65% |
| (i) Lease Liabilities | 21.80 | 20.49 | +6.39% |
| (ii) Other Financial Liabilities | 0.02 | – | – |
| b. Provisions | 16.08 | 17.34 | -7.27% |
| c. Deferred Tax Liabilities | 6.03 | 6.60 | -8.64% |
| Total Non-Current Liabilities | 43.93 | 44.44 | -1.15% |
| (i) Lease Liabilities | 4.38 | 3.27 | +33.94% |
| Dues of Micro and Small Enterprises | 0.80 | – | – |
| Dues of Other than Micro and Small Enterprises | 14.09 | 15.14 | -6.94% |
| (iii) Other Financial Liabilities | 39.31 | 27.16 | +44.73% |
| b. Other Current Liabilities | 50.58 | 45.09 | +12.18% |
| c. Provisions | 5.32 | 5.58 | -4.66% |
| d. Current Tax Liabilities (Net) | 3.21 | 1.56 | +105.77% |
| Total Current Liabilities | 117.68 | 97.80 | +20.33% |
| Total Liabilities | 161.61 | 142.24 | +13.62% |
| TOTAL EQUITY AND LIABILITIES | 1,104.74 | 957.74 | +15.35% |
CareEdge remains entirely debt-free, carrying zero long-term or short-term bank borrowings, debentures, or external commercial borrowings. Its total equity base reached ₹943.13 Crores (₹943.13 crore) as of March 31, 2026, financed by Retained Earnings of ₹560.45 Crores and General Reserves of ₹221.82 Crores. Current liabilities are comprised primarily of deferred contract liabilities (unearned rating and surveillance fees) of ₹39.35 Crores and performance-related incentive provisions of ₹38.35 Crores, reflecting an asset-light, cash-generative business model with a Current Ratio of 5.76 times.
Cash Flow: Tracking the Money Movement
The Consolidated Statement of Cash Flows shows the conversion of operating income into treasury liquidity alongside dividend disbursements.
| Consolidated Statement of Cash Flows (₹ in Crores) | FY 2025-26 | FY 2024-25 | Latest YoY (%) |
|---|---|---|---|
| Profit Before Tax | 235.35 | 192.27 | +22.41% |
| Operating Cash Flow Before Working Capital Changes | 199.45 | 161.76 | +23.30% |
| Net Working Capital Movements | 12.61 | 11.84 | +6.50% |
| Direct Taxes Paid (Net of Refund) | (64.49) | (50.65) | +27.32% |
| Net Cash Generated from Operating Activities (A) | 147.57 | 122.95 | +20.02% |
| Interest Received | 104.86 | 48.03 | +118.32% |
| Dividend Received | 0.20 | 0.18 | +11.11% |
| Proceeds from Fixed Deposits / Inter-Corporate Placements | 18.54% | 16.70% | – |
| Investment in Fixed Deposits | (649.82) | (532.79) | +21.97% |
| Acquisition of PPE, Intangible Assets Under Development & Advances | (8.30) | (14.74) | -43.69% |
| Proceeds / Buyback of Fixed Assets & Advances | 18.54% | 16.70% | – |
| Purchase of Investments | (360.49) | (89.20) | +304.14% |
| Redemption / Sale of Investments | 411.13 | 3.11 | +13119.61% |
| Net Cash Generated / (Used) in Investing Activities (B) | (94.45) | (58.43) | +61.65% |
| Dividend Paid to Shareholders | (58.36) | (54.91) | +6.28% |
| Proceeds from Exercise of Employee Share Options | 18.54% | 16.70% | – |
| ESOP Application Money Received | 0.13 | – | – |
| Principal Repayment of Lease Liabilities | (5.22) | (1.19) | +338.66% |
| Payment of Interest on Lease Liabilities | (2.49) | (2.11) | +18.01% |
| Net Cash Used in Financing Activities (C) | (59.33) | (54.00) | +9.87% |
| Net Increase / (Decrease) in Cash & Cash Equivalents (A + B + C) | (6.22) | 10.53 | N/M |
| Cash and Cash Equivalents at Beginning of Year | 48.82 | 38.29 | +27.50% |
| Cash and Cash Equivalents at End of Year | 42.60 | 48.82 | -12.74% |
Operating cash generation rose 20.02% to ₹147.57 Crores, providing internal cash funding for treasury investments, technology deployments, and shareholder returns. Capital deployment centered on term deposits with scheduled commercial banks, with net placement of fresh fixed deposits exceeding ₹242.10 Crores during the year. Total dividend payouts absorbed ₹58.36 Crores, while overall liquid treasury holdings across mutual funds, bank fixed deposits, and operational cash stood at ₹9.16 Crores (₹9.16 crore) on a consolidated basis.
Funding the Future: CapEx, CWIP & R&D Spending
As a service-driven analytical institution, physical capital expenditure additions remained disciplined, totaling ₹0.07 Crores in Property, Plant and Equipment and ₹2.71 Crores in Intangible Software additions during FY 2025-26. Tangible additions focused on IT networking hardware, computational servers, and leasehold refurbishments across its Mumbai and GIFT City office facilities.
Intangible Assets Under Development stood at ₹5.32 Crores as of March 31, 2026 (compared to ₹2.92 Crores in FY 2024-25), reflecting multi-year development of the company’s Next-Generation Rating Platform, advanced machine-learning financial spreading modules, and API integration tools. The group held capital commitments (net of advances) of ₹0.02 Crores as of March 31, 2026. A subsidiary entity incurred internal software product research expenditure of ₹0.81 Crores.
🗺️ The Corporate Family Tree: Structure & Investments
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
The operational reach of CareEdge Group is executed through six direct and step-down subsidiaries disclosed in Form AOC-1:
| Entity Name | Reporting Period / Currency | % Shareholding | Total Assets (₹ in Crores) | Turnover (₹ in Crores) | Profit / (Loss) After Tax (₹ in Crores) |
|---|---|---|---|---|---|
| CARE Analytics and Advisory Private Limited (CAAPL) | (0.01) | 100% | 46.66 | 48.60 | 0.54 |
| CARE ESG Ratings Limited (CERL) | (0.01) | 100% | 7.91 | 1.99 | (2.06) |
| CareEdge Global IFSC Limited (CGIL) | (0.01) | 100% | 33.17 | 9.00 | (3.43) |
| CARE Ratings (Africa) Private Limited (CRAF) | (0.01) | 78% | 25.78 | 19.06 | 5.02 |
| CARE Ratings South Africa (Pty) Limited* | (0.01) | 78% | 0.93 | 0.12 | (1.24) |
| CARE Ratings Nepal Limited (CRNL) | (0.01) | 51% | 15.27 | 7.51 | 3.42 |
*Note: CARE Ratings Limited holds 78% in CRAF, which in turn owns 100% of CARE Ratings South Africa (Pty) Limited. The Group has no associate companies or joint ventures under Part B of Form AOC-1.
Strategic Investments & Treasury Holdings
The company maintains strategic minority equity holdings in international peer credit rating and credit intelligence institutions, classified under Fair Value through Other Comprehensive Income (FVTOCI):
- Malaysian Rating Corporation Berhad (MARC): Holds 20,00,000 ordinary shares of RM 1 each, with a carrying fair value of ₹0.23 Crores as of March 31, 2026. MARC yielded ₹0.20 Crores in dividend income during the fiscal year.
- Kunsmatige Intelligensie Beleggings Limited (formerly ARC Risk Group Limited, BVI): Holds 20 ordinary shares of USD 22,600 each, carrying a fair value of ₹2.10 Crores as of March 31, 2026.
- Fixed-Income Treasury Book: Holds tax-free municipal and infrastructure bonds of ₹18.71 Crores, quoted Public Sector Undertaking (PSU) bonds of ₹0.41 Crores (across non-current and current allocations), Everest Bank debentures of ₹0.06 Crores, and money market/short-term debt mutual fund units of ₹21.65 Crores.
👥 Power & Control: Who Pulls the Strings?
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
The governance structure of CARE Ratings Limited is driven by a majority-independent Board of Directors, ensuring fiduciary oversight and operational independence:
| Name of Director / KMP | Designation & Category | DIN / Membership No. | Core Functional Experience & Professional Background |
|---|---|---|---|
| V. Chandrasekaran | Chairman, Non-Executive Independent Director | 03126243 | Taxation, finance, investments, corporate strategy, and corporate governance. Sits on boards of Grasim Industries and UltraTech Cement. |
| Mehul Pandya | Managing Director & Group CEO | 07610232 | Technocrat, BE, MBA, CFA Charterholder. Over 25 years with CareEdge; Vice Chairman of ACRAA; Co-Chair of CII National Committee on Financial Markets. |
| Gurumoorthy Mahalingam | Non-Executive Independent Director | 09660723 | Central banking, financial regulations, and debt markets. Former Executive Director of RBI and Whole-Time Member of SEBI. |
| Manoj Chugh | Non-Executive Independent Director | 02640995 | Technology architecture, enterprise IT infrastructure, and digital transformation strategy. Leadership background across global tech enterprises. |
| Rajiv Bansal | Non-Executive Independent Director | 00245460 | Corporate finance, risk advisory, and capital market governance. Appointed May 30, 2025; Public Interest Director on the Board of BSE Limited. |
| Indrani Banerjee | Non-Executive Independent Director | 09043941 | Financial services, banking operations, risk assessment, and legal frameworks. Appointed May 30, 2025. |
| Dr. Bimal Patel | Non-Executive Independent Director | 03006605 | International law, public policy, institutional governance, and regulation. Appointed November 12, 2025. |
| Jinesh Shah | Group Chief Financial Officer (KMP) | M. No. 117833 | Chartered Accountant; heads group financial reporting, balance sheet strategy, capital allocation, and statutory taxation frameworks. |
| Manoj Kumar C.V. | Company Secretary & Compliance Officer (KMP) | M. No. A15140 | Corporate secretarial compliance, SEBI Listing Regulations, legal governance, and stakeholder interface. Appointed September 1, 2024. |
Who Owns the Stock? Shareholding Pattern
As of March 31, 2026, the company’s authorized share capital stood at ₹35,00,00,000 (3,50,00,000 equity shares of ₹10/- each), with a paid-up equity share capital of ₹30,04,70,130 comprising 3,00,47,013 fully paid equity shares. The entire shareholding is 100% dematerialized across 58,914 individual and institutional accounts.
| Shareholder Category | Number of Shares Held | Percentage (%) of Equity Capital |
|---|---|---|
| I. Promoters & Promoter Group | – | 0.00% |
| Resident Individuals | 71,77,993 | 23.89% |
| Foreign Portfolio Investors (Corporate / FIIs) | 69,84,497 | 23.24% |
| Mutual Funds | 50,93,422 | 16.95% |
| Bodies Corporate | 50,38,345 | 16.77% |
| Qualified Institutional Buyers / Insurance Companies | 30,71,382 | 10.22% |
| Alternative Investment Funds (AIF) | 12,65,751 | 4.21% |
| Non-Resident Indians (Repatriable & Non-Repatriable) | 7,51,649 | 2.50% |
| Employees | 3,14,822 | 1.05% |
| Hindu Undivided Families (HUF) | 2,59,926 | 0.87% |
| Directors and their Relatives (Mehul Pandya) | 72,188 | 0.24% |
| Trusts, Clearing Members, NBFCs, Banks, IEPF, Others | 17,038 | 0.06% |
| Total Shareholding | 3,00,47,013 | 100.00% |
The top institutional shareholders as of March 31, 2026, include Life Insurance Corporation of India (9.49%), peer rating agency CRISIL Limited (8.73%), Nippon India Small Cap Fund (7.92%), Pari Washington India Master Fund (5.99%), ICICI Prudential Smallcap Fund (2.71%), Pari Washington Investment Fund (2.50%), and India Insight Value Fund (2.47%).
🎯 The Strategic Outlook: Future Plans & Potential Pitfalls
Competitive Advantages & Economic Moats
CareEdge operates within an industry characterized by high regulatory barriers to entry and reputation-based moats:
- Dual Regulatory Accreditation & High Barriers to Entry: The domestic credit rating landscape in India is governed by stringent SEBI and RBI accreditations. Capital adequacy frameworks (Basel III) require bank borrowers to obtain eligible credit assessments, positioning CareEdge as an essential intermediary for debt syndication and corporate bond issuance.
- Quality-Led Analytical Moat: Despite macroeconomic volatility, steep US tariffs on Indian exporters, and geopolitical shifts, CareEdge maintained an industry-leading default performance among its investment-grade rated portfolio. The group’s credit ratio (upgrades to downgrades) moderated from 2.56x in H1 FY26 to 1.93x in H2 FY26, capturing emerging stress without systemic default surprises.
- Pioneering Sovereign Rating Agency: Through CareEdge Global IFSC, the group operates as the first non-Western alternative CRA originating from an emerging economy to assign global-scale sovereign ratings. With coverage spanning 45 sovereigns (over 85% of global GDP), its proprietary model has been independently validated by academic institutions and backed by equity investments from the State Bank of India (SBI) and NSE IX.
- ESG Market Dominance: With a 58% domestic market share in Category 1 Issuer-Pays ESG ratings, the group holds a first-mover advantage as SEBI mandates Business Responsibility and Sustainability Reporting (BRSR Core) assurance for Indian listed corporates.
What Could Go Wrong? Key Challenges & Business Risks
Despite its debt-free balance sheet, several operational, market, and regulatory risks could impact future performance:
- Regulatory & Legal Contingencies: The company is appealing an enhanced SEBI penalty of ₹0.01 crore before the Securities Appellate Tribunal (SAT) regarding historical credit ratings assigned to an infrastructure client and its subsidiaries. Concurrently, in a lawsuit filed by 63 Moons Technologies Ltd., the Madras High Court directed the company to furnish security of 10% of the claim value. While CareEdge secured interim appeals and evaluated the outflow risk as remote, negative legal developments pose reputational and financial risks.
- Wholesale Debt Market Volatility: In FY 2025-26, corporate bond issuances declined by 3.2% (or 3.3% as per the Directors’ Report) to ₹10.7 trillion as large corporate borrowers shifted toward commercial bank credit. Sustained weakness in corporate bond issuances or delayed private capital expenditure can constrain initial rating fee generation.
- Internal Ratings-Based (IRB) Risk: A major share of domestic rating volume is driven by Basel III capital requirements for commercial banks. If the Reserve Bank of India permits commercial banks to adopt advanced Internal Rating-Based (IRB) approaches for capital computation, the mandatory requirement for external bank loan credit ratings may diminish.
- Unhedged Foreign Exchange Exposure: The group holds foreign-currency assets and unbilled contracts across USD, NPR, and MUR. A 100 bps shift in foreign exchange rates creates an estimated profit impact of ₹0.13 Crores for USD exposures and ₹0.0041 Crores for NPR exposures.
The Next Chapter: Growth & CapEx Initiatives
CareEdge’s strategic roadmap for FY 2026-27 is anchored around four growth drivers:
- Enterprise-Wide AI & Platform Commercialization: Deepening the operational footprint of EdgeAvira.AI and ReInvitEdge to license AI-powered risk assessment software to commercial banks, NBFCs, and sovereign wealth funds across South Asia, the Middle East, and Africa. Internal AI adoption reached over 60% across ratings workflows in FY 2025-26, targeting improved analytical turnaround times.
- Expansion of Sovereign & Cross-Border Rating Coverage: Scaling CareEdge Global IFSC’s presence across the African Union, Eastern Europe, and Latin America. Following initial mandates in fund valuation and debt ‘use-of-proceeds’, the group is exploring regulatory accreditation across target foreign jurisdictions.
- PaRRVA Expansion: Collaborating with the National Stock Exchange of India (NSE) to scale the Past Risk and Return Verification Agency (PaRRVA), providing standardized return auditing for SEBI-registered portfolio managers, research analysts, and algorithmic trading entities.
- Sustainable Finance & Third-Party Verification: Expanding Second Party Opinions (SPO) and Third-Party Reviews (TPRs) for green bonds, sustainability-linked instruments, and municipal climate financing, building on its assignment rating the first sustainability-linked local currency bond in Mauritius.
The Verdict: Strategic Outlook & Conclusion
CARE Ratings Limited concluded FY 2025-26 with a debt-free balance sheet, consolidated net worth of ₹943.13 Crores (₹943.13 crore), and total cash and liquid treasury assets of ₹9.16 Crores (₹9.16 crore). Revenue from operations expanded 17.59% to ₹473.07 Crores, driving a 24.07% expansion in Consolidated Net Profit to ₹173.70 Crores. Backed by high operational margins (Consolidated EBITDA margin of 41.73%, Standalone EBITDA margin of 48.33%), zero leverage, and an expanding international and analytics footprint, CareEdge remains well-positioned to benefit from the institutional deepening of India’s debt capital markets and the globalization of emerging-market credit intelligence.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.careedge.in/